发明授权
US09044460B2 Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
有权
针对表皮生长因子受体（EGFR）的抗体及其用途
- 专利标题： Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
- 专利标题（中）： 针对表皮生长因子受体（EGFR）的抗体及其用途
-
申请号： US13100920申请日： 2011-05-04
-
公开(公告)号： US09044460B2公开(公告)日： 2015-06-02
- 发明人: Raghida Bukhalid , Michael Feldhaus , Anne King , Neeraj Kohli , Eric Krauland , Ulrik Nielsen
- 申请人： Raghida Bukhalid , Michael Feldhaus , Anne King , Neeraj Kohli , Eric Krauland , Ulrik Nielsen
- 申请人地址： US MA Cambridge
- 专利权人： Merrimack Pharmaceuticals, Inc.
- 当前专利权人： Merrimack Pharmaceuticals, Inc.
- 当前专利权人地址： US MA Cambridge
- 代理机构： Nelson Mullins Riley & Scarborough LLP
- 代理商 Jane E. Remillard, Esq.; Jill Gorny Sloper, Esq.
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07K16/28 ; A61K39/00
摘要：
Anti-EGFR antibodies, therapeutic compositions comprising combinations of anti-EGFR antibodies, as well as methods for using such antibodies and compositions to treat EGFR-related disorders (e.g., cancers), are disclosed.
公开/授权文献
信息查询
